Answers are grounded in this paper and cite their sources.
Prednisone was used in the treatment of 30 consecutive patients with ITP (idiopathic thrombocytopenic purpura) under conditions that permitted the establishment of a satisfactory base line for metabolic and hematological studies, especially as to platelet count and other coagulation studies. Eleven cases were of the "acute," and 19 cases of the chronic type. The initial dose of prednisone varied between 20 and 150 mg. per day, given by mouth. The results ranged from complete absence of response to sustained remission without apparent need of further treatment. In 22 of the 30 cases the platelet count rose from the initial low values to normal in 6 to 150 days. Much individual adjustment of dosage was necessary. Maintenance dosages ranged from 2.5 to 15 mg. per day, but in eight patients it was possible to withdraw the prednisone entirely after establishing a normal platelet count. Splenectomy was performed in five patients of this series but was followed by complete, sustained remission in only one case. These results lead to the conclusion that in the treatment of ITP chief reliance should be placed upon such measures as prednisone therapy and transfusions, splenectomy being reserved for the occasional severe cases that do not respond to medical measures.
No takes yet. Share an insight, caveat, or question.
William Dameshek (1958) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: